Review
From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era
Pages (1434-1449)
Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions
Pages (1450-1459)
Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation
Pages (1460-1465)
Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms
Pages (1466-1475)
Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor: status and perspectives
Pages (1476-1493)
From cell signaling to cancer therapy
Pages (1494-1498)
Roles of secreted frizzled-related proteins in cancer
Pages (1499-1504)
Editorial
Review
Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals
Pages (1274-1304)
Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy
Pages (1305-1315)
Leukemia, an effective model for chemical biology and target therapy
Pages (1316-1324)
Emerging roles of deubiquitinating enzymes in human cancer
Pages (1325-1330)
Keap1 eye on the target: chemoprevention of liver cancer
Pages (1331-1342)
Discovery and development of sulforaphane as a cancer chemopreventive phytochemical
Pages (1343-1354)
Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents
Pages (1365-1372)
Vitamin D and prevention of breast cancer
Pages (1373-1382)
Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention
Pages (1383-1391)
Tea beverage in chemoprevention and chemotherapy of prostate cancer
Pages (1392-1408)
Original Article
